These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Therapeutic approaches in patients with inflammatory myopathies. Dalakas MC Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]
14. Newer therapeutic approaches: inflammatory muscle disorders. Di Martino SJ; Kagen LJ Rheum Dis Clin North Am; 2006 Feb; 32(1):121-8, ix. PubMed ID: 16504825 [TBL] [Abstract][Full Text] [Related]
15. [Dermatomyositis and polymyositis: clinical aspects and treatment]. Hachulla E Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory muscle disease: therapeutic aspects. Catoggio LJ; Soriano ER Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):55-71. PubMed ID: 10882214 [TBL] [Abstract][Full Text] [Related]
17. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy. Bronner IM; Hoogendijk JE; Wintzen AR; van der Meulen MF; Linssen WH; Wokke JH; de Visser M J Neurol; 2003 Apr; 250(4):480-5. PubMed ID: 12700915 [TBL] [Abstract][Full Text] [Related]
18. Tachyphylaxis of intravenous immunoglobulin in refractory inflammatory myopathy. Reimold AM; Weinblatt ME J Rheumatol; 1994 Jun; 21(6):1144-6. PubMed ID: 7932431 [TBL] [Abstract][Full Text] [Related]
19. Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies. Kissel JT Semin Neurol; 2002 Mar; 22(1):41-51. PubMed ID: 12170392 [TBL] [Abstract][Full Text] [Related]